Menu
Back to User profile » Dr Syed Nasir Abbas Bukhari
Papers published by Dr Syed Nasir Abbas Bukhari:
Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights
Abdelgawad MA, Musa A, Almalki AH, Alzarea SI, Mostafa EM, Hegazy MM, Mostafa-Hedeab G, Ghoneim MM, Parambi DGT, Bakr RB, Al-Muaikel NS, Alanazi AS, Alharbi M, Ahmad W, Bukhari SNA, Al-Sanea MM
Drug Design, Development and Therapy 2021, 15:2325-2337
Published Date: 31 May 2021
Molecular Epidemiology of Extensively-Drug Resistant Acinetobacter baumannii Sequence Type 2 Co-Harboring blaNDM and blaOXA From Clinical Origin
Ejaz H, Ahmad M, Younas S, Junaid K, Abosalif KOA, Abdalla AE, Alameen AAM, Elamir MYM, Bukhari SNA, Ahmad N, Qamar MU
Infection and Drug Resistance 2021, 14:1931-1939
Published Date: 25 May 2021
Enhanced immunosuppressive effects of 3,5-bis[4(diethoxymethyl)benzylidene]-1-methyl-piperidin-4-one, an α, β-unsaturated carbonyl-based compound as PLGA-b-PEG nanoparticles
Arshad L, Jantan I, Bukhari SNA
Drug Design, Development and Therapy 2019, 13:1421-1436
Published Date: 30 April 2019
Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compounds
Alkhaldi AAM, de Koning HP, Bukhari SNA
Drug Design, Development and Therapy 2019, 13:1179-1185
Published Date: 24 April 2019
Linseed hydrogel-mediated green synthesis of silver nanoparticles for antimicrobial and wound-dressing applications
Haseeb MT, Hussain MA, Abbas K, Youssif BGM, Bashir S, Yuk SH, Bukhari SN
International Journal of Nanomedicine 2017, 12:2845-2855
Published Date: 6 April 2017
Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines
Jantan I, Bukhari SNA, Adekoya OA, Sylte I
Drug Design, Development and Therapy 2014, 8:1405-1418
Published Date: 16 September 2014